Gossamer Bio, Inc. (GOSS)
0.2101
+0.01
(+4.58%)
USD |
NASDAQ |
May 22, 16:00
0.2158
+0.01
(+2.71%)
After-Hours: 20:00
Gossamer Bio EPS Diluted (Quarterly) : -0.1993 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | -0.8168 |
| Gilead Sciences, Inc. | 1.612 |
| Ironwood Pharmaceuticals, Inc. | 0.2446 |
| REGENXBIO, Inc. | -1.718 |
| CytomX Therapeutics, Inc. | -0.1029 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -46.66M |
| Revenue (Quarterly) | 16.96M |
| Total Expenses (Quarterly) | 63.62M |
| Enterprise Value | 153.03M |
| Gross Profit Margin (Quarterly) | 98.63% |
| Profit Margin (Quarterly) | -275.2% |
| Earnings Yield | -374.9% |
| Normalized Earnings Yield | -363.97 |